Genetic Pathogenesis of Hypertrophic and Dilated Cardiomyopathy

Area of Science:

• Cardiovascular Medicine
• Genetics
• Molecular Biology

Background:

• Sarcomere cardiomyopathies are inherited conditions affecting heart muscle contractility.
• These diseases cause abnormal thickening (hypertrophic) or enlargement (dilated) of the heart muscle.
• Early detection of genetic mutations is key to understanding disease mechanisms.

Purpose of the Study:

• To review the current understanding of how mutations linked to hypertrophic cardiomyopathy and hypertrophic dilated cardiomyopathy affect sarcomere structure and function.
• To highlight the earliest biomechanical defects in preclinical mutation carriers.
• To identify potential therapeutic pathways for preventing or mitigating cardiomyopathy.

Main Methods:

• Review of existing literature on sarcomere cardiomyopathies.
• Analysis of studies identifying preclinical mutation carriers.
• Synthesis of data on the molecular pathophysiology of hypertrophic and dilated cardiomyopathies.

Main Results:

• Pathogenic variants in sarcomere genes disrupt normal sarcomere structure and biomechanics.
• Early molecular defects precede overt cardiac dysfunction and remodeling.
• Understanding these early changes is crucial for developing targeted interventions.

Conclusions:

• Genetic mutations impacting the sarcomere are the root cause of these cardiomyopathies.
• Intervention strategies targeting early biomechanical defects may prevent or delay disease onset.
• Further research into sarcomere pathophysiology can lead to novel therapeutic approaches for heart muscle diseases.